Victor Fedorenko

Victor Fedorenko

Auto-generated profile, based on publicly available information

Victor Fedorenko

Department of Genetics and Biotechnology, Ivan Franko National University of Lviv, Lviv, Ukraine

Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2011 in Applied and Environmental Microbiology
Verified
Journal Article
Closed access
MMMaksym Myronovskyi
Maksym Myronovskyi
EWElisabeth Welle
Elisabeth Welle
VFViktor Fedorenko
Viktor Fedorenko
ALAndriy Luzhetskyy
Andriy Luzhetskyy
Here we describe a versatile and sensitive reporter system for actinomycetes that is based on gusA , which encodes the β-glucuronidase enzyme. A series of gusA- containing transcriptional and translational fusion vectors were constructed and utilized to study the regulatory cascade of the phenalinolactone biosynthetic gene cluster. Furthermore, these vectors were used to study the efficiency of translation initiation at the ATG, GTG, TTG, and CTG start codons. Surprisingly, constructs using a TTG start codon showed the best activity, whereas those using ATG or GTG were approximately one-half or one-third as active, respectively. The CTG fusion showed only 5% of the activity of the TTG fusion. A suicide vector, pKGLP2, carrying gusA in its backbone was used to visually detect merodiploid formation and resolution, making gene targeting in actinomycetes much faster and easier. Three regulatory genes, plaR1 , plaR2 , and plaR3 , involved in phenalinolactone biosynthesis were efficiently replaced with an apramycin resistance marker using this system. Finally, we expanded the genetic code of actinomycetes by introducing the nonproteinogenic amino acid N -epsilon-cyclopentyloxycarbonyl- l -lysine with the GusA protein as a reporter.

5 February 2014 in BMC Genomics
Verified
Journal Article
Open access
PDF file
NZNestor Zaburannyi
Nestor Zaburannyi
MRMariia Rabyk
Mariia Rabyk
BOBohdan Ostash
Bohdan Ostash
VFVictor Fedorenko
Victor Fedorenko
ALAndriy Luzhetskyy
Andriy Luzhetskyy
Background: The Streptomyces albus J1074 strain is one of the most widely used chassis for the heterologous production of bioactive natural products. The fast growth and an efficient genetic system make this strain an attractive model for expressing cryptic biosynthetic pathways to aid drug discovery. Results: To improve its capabilities for the heterologous expression of biosynthetic gene clusters, the complete genomic sequence of S. albus J1074 was obtained. With a size of 6,841,649 bp, coding for 5,832 genes, its genome is the smallest within the genus streptomycetes. Genome analysis revealed a strong tendency to reduce the number of genetic duplicates. The whole transcriptomes were sequenced at different time points to identify the early metabolic switch from the exponential to the stationary phase in S. albus J1074. Conclusions: S. albus J1074 carries the smallest genome among the completely sequenced species of the genus Streptomyces. The detailed genome and transcriptome analysis discloses its capability to serve as a premium host for the heterologous production of natural products. Moreover, the genome revealed 22 additional putative secondary metabolite gene clusters that reinforce the strain’s potential for natural product synthesis.

3 January 2012 in AMB Express
Verified
Journal Article
Open access
LHLiliya Horbal
Liliya Horbal
YRYuriy Rebets
Yuriy Rebets
MRMariya Rabyk
Mariya Rabyk
RMRoman Makitrynskyy
Roman Makitrynskyy
ALAndriy Luzhetskyy
Andriy Luzhetskyy
ABAndreas Bechthold
Andreas Bechthold
Analysis of the simocyclinone biosynthesis (sim) gene cluster of Streptomyces antibioticus Tü6040 led to the identification of a putative pathway specific regulatory gene simReg1. In silico analysis places the SimReg1 protein in the OmpR-PhoB subfamily of response regulators. Gene replacement of simReg1 from the S. antibioticus chromosome completely abolishes simocyclinone production indicating that SimReg1 is a key regulator of simocyclinone biosynthesis. Results of the DNA-shift assays and reporter gene expression analysis are consistent with the idea that SimReg1 activates transcription of simocyclinone biosynthesis, transporter genes, regulatory gene simReg3 and his own transcription. The presence of extracts (simocyclinone) from S. antibioticus Tü6040 × pSSimR1-1 could dissociate SimReg1 from promoter regions. A preliminary model for regulation of simocyclinone biosynthesis and export is discussed.

12 July 2014 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
LHLiliya Horbal
Liliya Horbal
VFVictor Fedorenko
Victor Fedorenko
ALAndriy Luzhetskyy
Andriy Luzhetskyy

1 October 2013 in Open Biology
Verified
Journal Article
Open access
RMRoman Makitrynskyy
Roman Makitrynskyy
BOBohdan Ostash
Bohdan Ostash
OTOlga Tsypik
Olga Tsypik
YRYuriy Rebets
Yuriy Rebets
EDEmma Doud
Emma Doud
VFVictor Fedorenko
Victor Fedorenko
Unlike the majority of actinomycete secondary metabolic pathways, the biosynthesis of peptidoglycan glycosyltransferase inhibitor moenomycin in Streptomyces ghanaensis does not involve any cluster-situated regulators (CSRs). This raises questions about the regulatory signals that initiate and sustain moenomycin production. We now show that three pleiotropic regulatory genes for Streptomyces morphogenesis and antibiotic production— bldA , adpA and absB —exert multi-layered control over moenomycin biosynthesis in native and heterologous producers. The bldA gene for tRNA Leu UAA is required for the translation of rare UUA codons within two key moenomycin biosynthetic genes ( moe ), moeO5 and moeE5 . It also indirectly influences moenomycin production by controlling the translation of the UUA-containing adpA and, probably, other as-yet-unknown repressor gene(s). AdpA binds key moe promoters and activates them. Furthermore, AdpA interacts with the bldA promoter, thus impacting translation of bldA -dependent mRNAs—that of adpA and several moe genes. Both adpA expression and moenomycin production are increased in an absB- deficient background, most probably because AbsB normally limits adpA mRNA abundance through ribonucleolytic cleavage. Our work highlights an underappreciated strategy for secondary metabolism regulation, in which the interaction between structural genes and pleiotropic regulators is not mediated by CSRs. This strategy might be relevant for a growing number of CSR-free gene clusters unearthed during actinomycete genome mining.

1 April 2004 in Chemistry & Biology
Verified
Journal Article
Closed access
BOBohdan Ostash
Bohdan Ostash
URUwe Rix
Uwe Rix
LRLily L.REmsing Rix
Lily L.REmsing Rix
TLTao Liu
Tao Liu
FLFelipe Lombó
Felipe Lombó
JRJürgen Rohr
Jürgen Rohr